An investigation on behalf of investors in Natus Medical Inc (NASDAQ:BABY) shares over potential wrongdoing at Natus Medical Inc was announced and NASDAQ:BABY stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 04/28/2016 -- An investigation was announced for investors in shares of Natus Medical Inc (NASDAQ:BABY) concerning potential breaches of fiduciary duties by certain directors.
Investors who purchased shares of Natus Medical Inc (NASDAQ:BABY) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Natus Medical directors breached their fiduciary duties and caused damage to the company and its shareholders.
On April 4, 2016, Natus Medical Inc announced its preliminary revenue for the quarter ended March 31, 2016. The CEO of Natus Medical Inc announced that due to, "pushouts of key orders in both our international and domestic markets, revenue for the first quarter of 2016 is now weaker than expected." Shares of Natus Medical Inc (NASDAQ:BABY) declined to as low as $29.54 per share on April 5, 2016.
Shares of Natus Medical Inc (NASDAQ:BABY) closed on April 27, 2016, at $33.74 per share.
Those who purchased shares of Natus Medical Inc (NASDAQ:BABY) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com